The future leaves
signals in time.

An NVIDIA Technical Blog post presents the NVIDIA Open Agent Safety Platform as a reference for continuous in-silicon monitoring of AI agents. The supplied context is limited and provides no further details.

An NVIDIA technical blog post describes OpenShell as a way to add runtime controls to AI agents. It notes that AI agents can be given a goal, write code, use tools, and keep working as new information becomes available; the available context is limited and further details are not provided.

ScienceDaily published this update. Read the original source for full details, conditions and limitations.

GPT-6 Astra finished a 50‑tab tax workbook twice as fast as GPT‑5.6 Sol, and Basis said its better understanding of user intent gives more confidence in real‑world use.

Nature Biotechnology published this update. Read the original source for full details, conditions and limitations.

Nature Biotechnology published this update. Read the original source for full details, conditions and limitations.

Nature Medicine published this update. Read the original source for full details, conditions and limitations.

The article explores emerging genome editing tools that could exceed CRISPR's capabilities, offering a guide to these new editors.

A Nature Biotechnology item indicates that cargo size is a consideration when designing lipid nanoparticles (LNPs) intended to deliver large gene editors. No further context was provided, so specific study details and conclusions are not stated here.

Nature Biotechnology published an item on AI-guided optimization for thermostable mRNA vaccines. The available context provides no further details on the methods, study stage, or outcomes, so no results can be confirmed from this item alone.

A Nature Biotechnology headline reports that lipid nanoparticles optimized for large RNA cargo and tissue targeting enhance in vivo genome editing. No supporting context was supplied, so methods, models and specific results are not available.

A large health-record analysis found glucosamine use associated with a 25% higher likelihood of mild cognitive impairment progressing to dementia. Lab experiments suggest it may intensify an abnormal sugar-tagging process in the Alzheimer’s brain, but clinical trials are needed to determine actual harm.

According to the randomized SINGLE-AF trial, direct oral anticoagulants cut the risk of serious clinical events by 69% in atrial fibrillation patients with an intermediate risk of stroke. The reported benefit was driven mainly by fewer ischemic strokes, with no increase in major bleeding.

A single dose of an experimental CRISPR therapy lowered LDL cholesterol and triglycerides by about half in patients with difficult-to-treat lipid disorders, with reductions still present one year later. At the highest dose, LDL fell 52.5% and triglycerides fell 47.8%; the therapy remains experimental.

Scientists have mapped the genetics of cat cancer at an unprecedented scale and found surprising similarities with tumors in humans. They say the findings could help bring precision cancer treatments to cats and offer new clues about how human cancers develop and respond to drugs.

A new analysis reexamined all eight major randomized screening trials, accounting for differences in follow-up time, screening frequency, and screening after the trials ended. Its results were consistent with an overdiagnosis rate below 5%, rather than earlier estimates approaching 30% to 50%, suggesting mammography overdiagnosis may be far lower than some prior studies indicated.

Proaction uses Codex, GPT-Live-1, and GPT-6 Astra to build, operate, and sell modern fleet management more quickly.